Biotech

News

Dr Fred Aslan, Artiva's president and chief executive

Artiva announces terms for its second IPO attempt

After abandoning its first initial public offering (IPO) filed in 2021, natural killer (NK) cell therapy specialist Artiva Biotherapeutics is having another go.

News

Novo leads $100m financing for Alzheimer's player Asceneuron

Novo Nordisk's parent company, Novo Holdings, has led a $100 million third-round financing for Swiss biotech Asceneuron, which is developing a non-amyloid therapy for Alzheimer's disease.

News

UK’s Destiny Pharma hops on the AIM delisting train

Destiny Pharma has joined a growing list of UK biotechs seeking to delist from the Alternative Investments Market (AIM) and return to private ownership.

News

Noubar Afeyan, founder and chief executive of Flagship Pioneering

Flagship closes $3.6bn biotech fund, with a focus on AI

Venture capital group Flagship Pioneering has raised $2.6 billion to support the development of around 25 startups operating in human health, sustainability, and artificial intelligence, wi

News

Myricx founders (l-r) Dr Andrew Bell, Dr Roberto Solari and Professor Ed Tate, with CEO Dr Robin Carr

Myricx raises £90m after pivot to ADCs for cancer

UK biotech Myricx Bio has tapped into the red-hot interest among investors for companies working on antibody-drug conjugates (ADCs) for cancer, raising £90 million ($115 million) in a first

News

Beacon lights up with $170m for retinal disease gene therapy

UK-headquartered Beacon Therapeutics has raised a whopping $170 million in second-round financing that will be used to advance a gene therapy for an inherited cause of blindness through a p

Artiva announces terms for its second IPO attempt

Novo leads $100m financing for Alzheimer's player Asceneuron

UK’s Destiny Pharma hops on the AIM delisting train

Flagship closes $3.6bn biotech fund, with a focus on AI

Myricx raises £90m after pivot to ADCs for cancer

Beacon lights up with $170m for retinal disease gene therapy

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

Biotech

Editor's Picks